Parallel Bio
Harnessing the immune system to cure disease
Parallel Bio is a drug discovery company that has built a platform centered on a map of human biology. The core problem it addresses is the high failure rate of drugs in human trials, which the company attributes to traditional discovery methods that rely on animal models. By using human immune organoids, patient samples, and computational tools, the platform aims to generate insights that are directly relevant to human biology, bypassing the limitations of animal-based testing.
The platform integrates biological and computational capabilities. Its key components include a scalable human immune organoid system, a biobank of patient samples covering diverse backgrounds, and a suite of computational tools for analysis. The company’s work spans three main areas: drug discovery from target identification to IND, precision medicine through patient stratification, and the development of foundation models built on continuously generated human biological data. The platform is designed to model how therapies perform across different patient populations.
The platform is intended for pharmaceutical companies and drug developers seeking to improve the predictability of their preclinical research. The company reports working with several partners, including Fortune 500 companies. Information on specific pricing, free plans, trials, or seat-based versus usage-based packaging is not provided on the available pages.
12 alternatives to Parallel Bio
Ranked by how well each tool replaces Parallel Bio: shared features, audience, price and popularity.
Web infrastructure for AI to search, extract, monitor, and reason over the world's info.
Covers 4 of 15 key features and has a free plan.
Free plan64 out of 100 matchFreeCRISPR gene modulation and AI for cancer and inflammation treatments
Covers 10 of 15 key features.
62 out of 100 match—- 61 out of 100 matchUsage-based
Accelerate biologics discovery with cutting-edge bioinformatics
Covers 0 of 15 key features.
60 out of 100 matchContact salesAI infrastructure software portfolio.
Covers 3 of 15 key features and has a free plan.
Free plan56 out of 100 match$700/moDiscover Cures for Genetic Diseases with Rosebud Biosciences
Covers 0 of 15 key features.
56 out of 100 match—AI-native software for protein characterization and peptide mapping.
Covers 3 of 15 key features.
56 out of 100 match—The real-time search engine for AI agents
Covers 5 of 15 key features and has a free plan.
Free plan56 out of 100 matchFree- 55 out of 100 matchContact sales
What if we made as many cancer drugs next year as we have in the last decade?
Covers 0 of 15 key features.
55 out of 100 match—